Filing Details

Accession Number:
0001348362-24-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-03 14:03:28
Reporting Period:
2024-12-02
Accepted Time:
2024-12-03 14:03:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1348362 Lexaria Bioscience Corp. LEXX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1271244 Richard Christopher C/O Lucid, Inc.
50 Methodist Hill Dr, Suite 1000
Rochester NY 14623
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2024-12-02 22,828 $2.24 22,828 No 4 P Direct
Common Shares Acquisiton 2024-12-03 27,172 $2.47 50,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Stock Options $3.92 2025-02-28 2029-08-31 200,000 200,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2029-08-31 200,000 200,000 Direct
Footnotes
  1. Options are vested as to 50,000 on February 28, 2025 with 6,818 being vested monthly thereafter until November 30, 2026 whereby the balance of 6,822 options will be vested on December 31, 2026